Page 2 - Modernization Action Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Modernization Action Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Modernization Action Plan Today - Breaking & Trending Today

ArisGlobal: The FDA Goes Live with LifeSphere MultiVigilance, Modernizing Pharmacovigilance Capabilities with FAERS II

Published: December 15, 2021

ArisGlobal's industry leading pharmacovigilance platform automates the intake, triage, and processing of over three million safety reports per year, improving regulatory processes and data quality. MIAMI

Source: finanznachrichten.de

Related Topics:

United StatesSankesh AbbhiArisglobal LifespherePrnewswire ArisglobalKostenloser WertpapierhandelLifesphere MultivigilanceUnited States Department Of HealthCustomer Value Leadership Award For Clinical DevelopmentHuman ServicesDrug Administration Adverse Event Reporting SystemCenters Of DrugLife SciencesPharmacovigilance SoftwareTechnology Modernization Action PlanModernization Action PlanUnited States DepartmentBiologic EvaluationSphere MultivigilanceIndividual Case Safety ReportsCustomer Value Leadership AwardClinical Development

The FDA Goes Live with LifeSphere MultiVigilance, Modernizing Pharmacovigilance Capabilities with FAERS II

Published: December 15, 2021

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com

Related Topics:

United StatesSankesh AbbhiArisglobal LifespherePrnewswire ArisglobalLifesphere MultivigilanceUnited States Department Of HealthCustomer Value Leadership Award For Clinical DevelopmentHuman ServicesDrug Administration Adverse Event Reporting SystemCenters Of DrugLife SciencesPharmacovigilance SoftwareTechnology Modernization Action PlanModernization Action PlanUnited States DepartmentBiologic EvaluationIndividual Case Safety ReportsCustomer Value Leadership AwardClinical DevelopmentPr NewswireUs Food And Drug Administration